欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/3248/003
药品名称Leflunomid Aurobindo
活性成分
    • leflunomide 20.0 mg
剂型Film-coated tablet
上市许可持有人Aurobindo Pharma (Malta) Limited Vault 14, Level 2 Valletta Waterfront, Valletta FRN 1913, Malta
参考成员国 - 产品名称Denmark (DK)
Leflunomide Aurobindo
互认成员国 - 产品名称
    • Germany (DE)
      Leflunomid Puren 20 mg Filmtabletten
    • Belgium (BE)
    • Netherlands (NL)
      Leflunomide Aurobindo 20 mg, filmomhulde tabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
      Leflunomide Aurovitas
许可日期2022/04/26
最近更新日期2024/04/12
药物ATC编码
    • L04AA13 leflunomide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase